Chandler, AZ, United States of America

Neil H Riordan

This inventor holds 14 USPTO granted patents and 15 published patent applications. Top assignees: The Center for the Improvement of Human Functioning, Int'l., Inc., The Center for the Improvement of Human Functioning, Int., Inc., Aidan Products, LLC. Active years: 1994-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Neil H Riordan. Retrieved from https://idiyas.com/inventor/neil-h-riordan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 14 

% Patents Active = 92.9

Average Co-Inventor Count = 1.5

ph-index = 5

Forward Citations = 77(Granted Patents)


Location History:

  • Wichita, KS (US) (1994 - 2002)
  • Chandler, AZ (US) (2002 - 2019)
  • Westlake, TX (US) (2021)

Company Filing History:


Years Active: 1994-2021

Loading Chart...
14 patents (USPTO):Explore Patents

Title: Neil H. Riordan: Innovator in Stem Cell Research

Introduction

Neil H. Riordan, an accomplished inventor based in Chandler, AZ, has made significant contributions to the field of regenerative medicine through his innovative research and patented inventions. With a remarkable portfolio of 14 patents, Riordan is recognized for his pioneering work in the use of mesenchymal stem cells for treating autoimmune conditions, particularly rheumatoid arthritis.

Latest Patents

Among Riordan's latest patents is one focused on "Mesenchymal stem cells with enhanced efficacy in treatment of autoimmunity particularly rheumatoid arthritis." This patent discloses protocols and compositions that identify mesenchymal stem cells possessing enhanced clinical activity in addressing autoimmune disorders. Additionally, it highlights specific markers that can signal the superiority of certain mesenchymal stem cells from donors, enhancing their efficacy in treating conditions like rheumatoid arthritis.

Another noteworthy patent by Riordan is titled "Stem cell/endothelial progenitor cell mobilization by nutraceutical formulations." This invention introduces various formulations of food supplements that elicit mobilization of stem/progenitor cells, including hematopoietic stem cells and endothelial progenitor cells. The patent describes a unique mixture made of ellagic acid, vitamin D3, beta 1,3 glucan, and various extracts, originally developed as an immune stimulant that unexpectedly promotes stem cell mobilization.

Career Highlights

Neil H. Riordan has held pivotal roles at several renowned institutions, including the Center for the Improvement of Human Functioning. His dedication to advancing medical science through innovative approaches has propelled him to the forefront of stem cell therapy research.

Collaborations

Throughout his career, Riordan has collaborated with esteemed colleagues such as Hugh D. Riordan and XiaoLong Meng. Their collective efforts have fostered advancements in medical research and have had a profound impact on treating autoimmune diseases.

Conclusion

In summary, Neil H. Riordan's innovative spirit and scientific ingenuity have led to significant advancements in stem cell therapy. His contributions not only reflect his expertise but also highlight the potential for transformative treatments in the field of autoimmune conditions. As research continues to evolve, Riordan's work will undoubtedly remain influential, guiding future discoveries and innovations in regenerative medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…